- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01807312
The Application of CO2 Insufflations in Routine Colonoscopy Examination for Duration in Toilet After Examination Compared With Air Insufflations
It has been reported that carbon dioxide (CO2) insufflation can reduce patient pain and abdominal discomfort during and after colonoscopy. Its safety and efficacy during colonoscopy even under sedation has been already assessed in some earlier trials. Air insufflation is still the standard method, however, due a lack of suitable replacement of equipment or technical improvement in colonoscopy.
The investigators use radio frequency identification (RFID) technology to record the number of times and duration in the toilet of the patient after colonoscopy examination. These data may be proxies for discomfort. With application of CO2 insufflation, the times and duration in the toilet after examination will decrease as well as patient's discomfort after procedure, and further improvement of patient compliance can be anticipated.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It has been reported that carbon dioxide (CO2) insufflation can reduce patient pain and abdominal discomfort during and after colonoscopy. Its safety and efficacy during colonoscopy even under sedation has been already assessed in some earlier trials. Air insufflation is still the standard method, however, due a lack of suitable replacement of equipment or technical improvement in colonoscopy.
In laparoscopic surgery, CO2 insufflation is widely applied and safely used for patients under general anesthesia. CO2 insufflation is also applied in CT colonography for reduction of discomfort during or after procedure. During endoscopic procedure for colorectal neoplasia resection, however, long procedural time may increase not only the degree of discomfort during and after the procedure but also the risk of perforation. In addition to laparoscopic surgery, CO2 insufflation has also been applied to other endoscopic procedures. Saito et al reported the application of CO2 insufflation in endoscopic submucosal dissection (ESD) of colorectal neoplasia in a prospective study in which their average procedural time using CO2 insufflation was 90 minutes under conscious sedation with average of 5.6 mg of midazolam. When compared with control group using room air, statistically negligible difference of pCO2 was observed with significant difference in abdominal discomfort. Screening colonoscopy, which can be completed within 15 minutes if no lesion has been detected, requires high screenee satisfaction so as to improve patient compliance. In the setting of colonoscopy after positive FOBT, the attendance rate for secondary colonoscopy was around 60 to 70 % according to the data demonstrated in previous RCT and population-based studies.
Recently, radio frequency identification (RFID) technology, a 'wireless automatic identification and data capture (AIDC) technology has emerged as a multidimensional innovation that can accelerate the transformation of healthcare processes. The effective adoption and use of RFID technology is expected to transform intra- and inter-organisational business processes, thus allowing intra- and inter-firms business process innovation, real-time data collection and sharing at the supply chain level, business analytics and improved decision making. In the specific context of the healthcare sector, RFID technology offers a better means for patient identification, tracking, and tracing.We use radio frequency identification (RFID) technology to record the number of times and duration in the toilet of the patient after colonoscopy examination. These data may be proxies for discomfort. With application of CO2 insufflation, the times and duration in the toilet after examination will decrease as well as patient's discomfort after procedure, and further improvement of patient compliance can be anticipated.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan
- National Taiwan University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Subjects aged between 20 and 80 years who receive Screening colonoscopy
Exclusion criteria:
- Subjects who have chronic lung diseases or cardiovascular diseases
Study Plan
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: CO2 insufflation
CO2 insufflations was applicated in routine colonoscopy examination with Endoscopic CO2 regulation unit and accessories
|
Olympus UCR Endoscopic CO2 Regulation Unit
|
PLACEBO_COMPARATOR: Air insufflation
Air insufflations is applicated in Routine Colonoscopy Examination
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The number of times and duration in the toilet of the patient after colonoscopy examination
Time Frame: Two hours after examination
|
Two hours after examination
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the point of pain scoring system after colonoscopy examination
Time Frame: Two hours after examination
|
Two hours after examination
|
Collaborators and Investigators
Investigators
- Principal Investigator: Han-Mo Chiu, PhD, Department of Internal Medicine, National Taiwan University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 201211070RIC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carbon Dioxide Insufflation
-
Chang Gung Memorial HospitalCompletedCarbon Dioxide Insufflation During Colonoscopy
-
Zhongshan Hospital Xiamen UniversityActive, not recruitingColonoscopy | Gastrointestinal Microbiome | Appendix | Carbon Dioxide InsufflationChina
-
North Eastern Ohio Gastroenterology and Endoscopy...Mercy Health OhioUnknownCarbon Dioxide Insufflation | Anterograde Single Balloon EnteroscopyUnited States
-
Patrick BrooksMissouri State UniversityCompletedCarbon DioxideUnited States
-
Assiut UniversityCompletedCarbon DioxideEgypt
-
Wake Forest University Health SciencesAvita MedicalRecruitingPhotoaging | Carbon Dioxide LaserUnited States
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedVentilation | End-Tidal Carbon DioxideTurkey
-
Ramathibodi HospitalCompletedPartial Pressure of Carbon DioxideThailand
-
Istanbul UniversityRecruitingpH | Oxygen | End-tidal Carbon DioxideTurkey
-
Milton S. Hershey Medical CenterWithdrawnCarbon Dioxide Partial Pressure Determination, Transcutaneous
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy